atovaquone has been researched along with Cancer of Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Li, X; Luo, B; Sun, Y; Xu, H | 1 |
| Fowler, RE; Pudney, M; Sinden, RE | 1 |
2 other study(ies) available for atovaquone and Cancer of Liver
| Article | Year |
|---|---|
Inhibition of mitochondrial respiration overcomes hepatocellular carcinoma chemoresistance.
Topics: Animals; Antineoplastic Agents; Atovaquone; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Mice; Mice, Inbred NOD; Mice, SCID; Mitochondria; Structure-Activity Relationship; Tumor Cells, Cultured | 2019 |
Inhibitory activity of the anti-malarial atovaquone (566C80) against ookinetes, oocysts, and sporozoites of Plasmodium berghei.
Topics: Animals; Anopheles; Antimalarials; Atovaquone; Carcinoma, Hepatocellular; Culture Media; Flagella; Insect Vectors; Liver Neoplasms; Mice; Naphthoquinones; Plasmodium berghei; Tumor Cells, Cultured | 1995 |